PT-141
Bremelanotide — a centrally acting arousal peptide.
$189/mo
Choose your PT-141 plan
Visible results typically start around month 3. Lock in your supply upfront for the best per-month price.
Your final plan is confirmed by a US-licensed clinician after a brief intake. If you're not approved for treatment for any reason, you receive a full refund on the medication cost.
What is PT-141?
PT-141 (Bremelanotide) is a centrally acting melanocortin receptor agonist used to support sexual desire and arousal. Unlike PDE5 inhibitors, which act on blood flow, PT-141 works through the brain. Bremelanotide is FDA-approved as Vyleesi® for hypoactive sexual desire disorder (HSDD) in premenopausal women; other uses are off-label.
How it works
Melanocortin receptor agonism
PT-141 activates MC3 and MC4 receptors in the central nervous system, engaging the neural circuitry involved in desire and arousal.
Brain-based, not vascular
Because it works upstream of blood flow, it may help when PDE5 inhibitors aren't appropriate or aren't enough.
Non-hormonal
PT-141 does not act on testosterone or estrogen — a distinction your clinician will factor into your protocol.
Transformative results
- 01
Supports libido and arousal centrally rather than vascularly
- 02
May be considered when PDE5 inhibitors are unsuitable
- 03
Non-hormonal option
- 04
Subcutaneous, on-demand dosing
What's included
- Personalized protocol from a licensed US clinician
- Free, discreet shipping from a trusted US pharmacy
- Ongoing dose adjustments and progress reviews
- Unlimited messaging with your care team
- Flat monthly price — never changes with dose
Questions, answered.
Do I need insurance?
No. Pulse Labs Health membership pricing is transparent and does not require insurance.
How quickly can I start?
Most members complete intake and receive physician approval within 24 hours.
Is a provider available after I start?
Yes. Members have around-the-clock access to licensed US providers at no additional cost.
What if I'm not approved?
You aren't charged for treatment if a clinician determines it isn't right for you — 100% money-back on the medication cost.
Bremelanotide is FDA-approved as Vyleesi® for HSDD in premenopausal women; use in men is off-label. Risks, benefits, and alternatives are reviewed by a US-licensed clinician.
